The present invention provides substituted 11-phenyl-dibenzazepine compounds
which are specific, potent and safe inhibitors of mammalian cell proliferation.
The compounds can be used to inhibit mammalian cell proliferation in situ as a
therapeutic approach towards the treatment or prevention of diseases characterized
by abnormal cell proliferation, such as cancer.